Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia
Original Article
R. Savarirayan, J. Hoover-Fong, M. Irving, P. Arundel, J.M.d. Bergua, P.M. Campeau, T. Candler, B.T. Cocanougher, V. Cormier-Daire, T. Edouard, S.O. Fredwall, P. Harmatz, D. Hoernschemeyer, H.U. Irgens, S. Jamuar, P. Kannu, J.M. Legare, A. Leiva-Gea, H. McDevitt, R. Onesimo, J.P. III III, M.d. Pino, M.-E. Robinson, M. Rossi, M. Skae, L.M. Ward, K.K. White, J. Schmidt, T. Lystig, A. Salvatici, Y. Bai, P.W. Butler, D.v. Veenhuyzen, and D. Rogoff
N Engl J Med 2026;395:859-869
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
09/02/2026
Course expires:
09/03/2028
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward